We are Calcium phenylpyruvate CAS:51828-93-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Related News: The mode of cooperation between domestic API companies and large international companies can lower the export threshold.etil [(dimetilamino) iminometil] metilcarbamato CAS:62806-48-8 The mode of cooperation between domestic API companies and large international companies can lower the export threshold.2-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol CAS:61337-89-1 Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.1- (bromometil) -2- (trifluorometoxi) benceno CAS:198649-68-2 Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.
Product Name | |
---|---|
1-chloro-7-iodoheptane | View Details |
4,4,4-trifluorobutanenitrile | View Details |
L-Lysine Acetate | View Details |